The Institute of Cancer Research and biotechnology company NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of molecular glue degrader drugs. The collaboration ...
Neosphere Biotechnologies and Kymera Therapeutics partner to advance molecular glue target discovery
Neosphere Biotechnologies GmbH has entered into a collaboration with Kymera Therapeutics Inc. that seeks to unlock undrugged or poorly drugged disease-causing protein targets that can be addressed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results